Approval Letter ESPERION THERAPS INC (Jan 16, 2026)
FDA posted an approval letter for NEXLETOL on 2026-01-16. This is the document posting date; consult the signed letter for the decision date. The source metadata identifies NDA 211616 as a supplement. Review the exact FDA letter for the approved conditions and labeling.
